These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9296285)

  • 21. In vitro activity of netilmicin alone and in combination with azlocillin, mezlocillin and imipenem against 149 coagulase-negative staphylococci.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; D'Eletto MR; D'Antonio D; Ravagnan G
    Drugs Exp Clin Res; 1989; 15(6-7):303-8. PubMed ID: 2591301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase of imipenem resistance among Pseudomonas aeruginosa isolates from a Polish paediatric hospital (1993-2002).
    Patzer JA; Dzierzanowska D
    Int J Antimicrob Agents; 2007 Feb; 29(2):153-8. PubMed ID: 17157481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.
    Turner PJ
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):341-4. PubMed ID: 17049798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of in vivo intrinsic activity of cefepime and imipenem in a Pseudomonas aeruginosa rabbit endocarditis model: effect of combination with tobramycin simulating human serum pharmacokinetics.
    Navas D; Caillon J; Gras-Le Guen C; Jacqueline C; Kergueris MF; Bugnon D; Potel G
    J Antimicrob Chemother; 2004 Oct; 54(4):767-71. PubMed ID: 15317741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The postantibiotic effect of meropenem and imipenem on selected bacteria.
    Nadler HL; Pitkin DH; Sheikh W
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other carbapenems.
    Livermore DM; Mushtaq S; Warner M
    J Antimicrob Chemother; 2005 Mar; 55(3):306-11. PubMed ID: 15705643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa.
    Odenholt I; Isaksson B; Nilsson L; Cars O
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):136-41. PubMed ID: 2498095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of aztreonam-netilmicin association on outer membrane proteins of P. aeruginosa strains.
    Cipriani P; Giordano A; Magni A; Filadoro F
    Microbiologica; 1991 Oct; 14(4):301-5. PubMed ID: 1663572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of a postantibiotic effect in experimental Pseudomonas endocarditis treated with imipenem, with or without gentamicin.
    Hessen MT; Pitsakis PG; Levison ME
    J Infect Dis; 1988 Sep; 158(3):542-8. PubMed ID: 3137272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates.
    Altoparlak U; Aktas F; Celebi D; Ozkurt Z; Akcay MN
    Burns; 2005 Sep; 31(6):707-10. PubMed ID: 16129224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postantibiotic effects of norfloxacin and netilmicin and their influence on the biological properties of Salmonella strains.
    Majtán V; Majtánová L
    Pharmazie; 1998 Jun; 53(6):410-2. PubMed ID: 9675772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and bactericidal activity of a single daily dose of netilmicin in the treatment of CAPD-associated peritonitis.
    Anding K; Krumme B; Pelz K; Böhler J; Schollmeyer P
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):465-9. PubMed ID: 8937927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of doripenem.
    Sahm D
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S11-6. PubMed ID: 19619017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postantibiotic effect of norfloxacin and its influence on profiles of outer membrane proteins of Pseudomonas aeruginosa.
    Hostacká A; Karelová E
    Pharmazie; 1997 Mar; 52(3):238-9. PubMed ID: 9109171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro activity of netilmicin.
    Hussain Qadri SM; Johnson S
    J Okla State Med Assoc; 1984 Jul; 77(7):198-201. PubMed ID: 6432977
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison of the activity of netilmicin and gentamicin in vitro on bacteria isolated from the oro-pharynx].
    Pase U; Pascotto P; Bagolan A
    G Stomatol Ortognatodonzia; 1984; 3(3):355-7. PubMed ID: 6443212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.